Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Pinfeng Medical Technology

Request full access

Offers intelligent testing and precise diagnostic solutions to global in vitro diagnostic markets

ChinaFounded 2020Biotech & Life Sciences

About Shanghai Pinfeng Medical Technology

Shanghai Pinfeng Medical Technology, established in 2020, is a key player in the in-vitro diagnostics (IVD) sector, concentrating on the development of intelligent laboratory solutions. The company was founded by Ding Wei, a veteran with over two decades of experience in the global IVD field, who previously held executive positions at bioMérieux and Kehua Bio-engineering. His extensive background in product development, strategic acquisitions, and sales management within the diagnostics market underpins the company's direction.

Pinfeng Medical operates in the medical technology market, specifically targeting clinical laboratories in hospitals and other medical institutions. The firm's business model revolves around providing comprehensive solutions that encompass instruments, reagents, and software, aiming to capture the entire workflow of a clinical laboratory. This strategy addresses the market's shift towards greater automation and integrated information management. Revenue is generated through the sale of these integrated systems and associated consumables. The company is positioning itself to address the growing demand for efficiency and accuracy in clinical diagnostics, driven by policy support for 'Smart Hospitals' and payment reforms in China.

The core of Pinfeng's offering is the "i-Lab unattended laboratory," a concept designed to achieve complete automation and intelligent management from sample receipt to final result. This solution integrates robotics for sample handling and transport, advanced diagnostic instruments, and a sophisticated laboratory information management system to create a seamless workflow. Key products include the PINNACLES i-Lab, automated assembly lines like the S-LAS series, and a range of diagnostic instruments for immunoassay, clinical chemistry, and molecular diagnostics. A significant achievement is the partnership with the international firm INPECO to localize the production of the advanced FlexLab X automated system, enhancing its ability to serve the Chinese market with customized, high-throughput solutions.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
22.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Client focus
B2B
Investment activity
1 company, latest Jun 2024
Capital deployed
$0
Preferred round
SERIES A

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Aug 2023 $28M $110M Oriental Fortune Capital · Industrial Securities Capital · Yushan Partners · Tsing Song Capital ↗
SERIES AOther financing Oct 2021 $41M $165M Vertex Ventures China ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Pinfeng Medical Technology website traffic

Latest recorded traffic for Shanghai Pinfeng Medical Technology is 590 monthly website visits, up 883.3% over the last three months.

Latest monthly visits590 3-month web change+883.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Pinfeng Medical Technology in its local ecosystem

Live from Dealroom

The Shanghai Pinfeng Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Vertex Ventures China
  • Oriental Fortune Capital
  • Industrial Securities Capital
  • Yushan Partners
  • Tsing Song Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Pinfeng Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Pinfeng Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.